Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 16, 2016
William B. White Explains the Changes In the Way We Look at Blood Pressure: Which Numbers Matter Most-and Why Can They Be Deceptive?
Jack McCain
Managed Care (Langhorne, Pa.)
|
March 24, 2005
Managed care (and everyone else) unprepared for the next killer flu
Jack McCain
Managed Care (Langhorne, Pa.)
|
June 30, 2017
Chimeric Antigen Receptor T-Cell Therapy: The Next Big Thing Faces Challenges
Jack McCain
Managed Care (Langhorne, Pa.)
|
January 13, 2006
Flu's other cost
Jack McCain
Managed Care (Langhorne, Pa.)
|
July 21, 2004
Health plans respond as microbes develop resistance techniques
Jack McCain
Managed Care (Langhorne, Pa.)
|
February 22, 2014
Could QALYs help in assessing high-priced cancer treatments?
Jack McCain
Biotechnology Healthcare
|
August 10, 2012
Part 1: Distribution models for biologics and other specialty pharmaceutical products: In this first of a two-part series, we examine the distribution landscape for specialty pharmaceuticals. A manufacturer's strategy for the flow of product to patient has important implications for payers and for the success of a new biologic therapy
Jack McCain
Biotechnology Healthcare
|
October 24, 2012
Connecting Patients With Specialty Products: Part 2: The future of specialty drug distribution
Jack McCain
Managed Care (Langhorne, Pa.)
|
January 11, 2014
Choosing the right oral antiplatelet medication
Jack McCain
Biotechnology Healthcare
|
February 21, 2013
Shaking the tree of life
Jack McCain
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 16, 2016
William B. White Explains the Changes In the Way We Look at Blood Pressure: Which Numbers Matter Most-and Why Can They Be Deceptive?
Jack McCain
Managed Care (Langhorne, Pa.)
|
March 24, 2005
Managed care (and everyone else) unprepared for the next killer flu
Jack McCain
Managed Care (Langhorne, Pa.)
|
June 30, 2017
Chimeric Antigen Receptor T-Cell Therapy: The Next Big Thing Faces Challenges
Jack McCain
Managed Care (Langhorne, Pa.)
|
January 13, 2006
Flu's other cost
Jack McCain
Managed Care (Langhorne, Pa.)
|
July 21, 2004
Health plans respond as microbes develop resistance techniques
Jack McCain
Managed Care (Langhorne, Pa.)
|
February 22, 2014
Could QALYs help in assessing high-priced cancer treatments?
Jack McCain
Biotechnology Healthcare
|
August 10, 2012
Part 1: Distribution models for biologics and other specialty pharmaceutical products: In this first of a two-part series, we examine the distribution landscape for specialty pharmaceuticals. A manufacturer's strategy for the flow of product to patient has important implications for payers and for the success of a new biologic therapy
Jack McCain
Biotechnology Healthcare
|
October 24, 2012
Connecting Patients With Specialty Products: Part 2: The future of specialty drug distribution
Jack McCain
Managed Care (Langhorne, Pa.)
|
January 11, 2014
Choosing the right oral antiplatelet medication
Jack McCain
Biotechnology Healthcare
|
February 21, 2013
Shaking the tree of life
Jack McCain
Page
of 3